Medivir AB: Interim Report, 1 January – 30 June 2010
STOCKHOLM--(BUSINESS WIRE)--Medivir (STO:MVIRB):
•Consolidated net sales were SEK 36.2 (24.5) m.
•The consolidated loss for the period was SEK -50.3 (-62.9) m.
•Earnings per share for the period were SEK -2.14 (-3.02).
•Cash flow from operating activities was SEK 4.6 (-72.9) m.
•Cash and cash equivalents and investments in securities etc. at the end of the period were SEK 462.7 (210.9) m.